Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients (NCT05732779)
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients: Enhancing Technological Innovation and Strengthening the Role of Small Businesses in Meeting Needs of Adolescent Organ Transplant
🩺 Plain-English Summary (8th-Grade Level)
We will conduct a two-group randomized controlled trial to examine the eMocha DOT intervention with pediatric HT recipients.In this population, medication nonadherence remains a primary cause of late acute rejection (LAR) episodes, increased number of hospitalizations, graft failure, and patient mortality. Herein, we propose an innovative approach to promote medication adherence and improve patient and graft outcomes.
Who can join: Review the eligibility criteria below.
Location: University of Miami, Miller School of Medicine — Coral Gables, Florida
Age range: 10 Years to 21 Years
🧪 Interventions in This Study
- DOT intervention (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- University of Miami, Miller School of Medicine — Coral Gables, Florida
- University of Florida — Gainesville, Florida
- Joe DiMaggio Children's Hospital — Hollywood, Florida
- FSU College of Medicine — Tallahassee, Florida
📞 Contact the Study Coordinator
Phone: (352) 273-5422
Email: dgupta@ufl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Transplant Rejection
- Surveillance HeartCare® Outcomes Registry — Phoenix, Arizona
- Prospera Test Evaluation in Cardiac Transplant (ProTECT) — San Carlos, California
- Trifecta-Heart cfDNA-MMDx Study — Little Rock, Arkansas
Explore by condition: All Heart Transplant Rejection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.